Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMNM stock hub

Immunome, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMNMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMNM

In the news

Latest news · IMNM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-52.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-32.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMNM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001472012
Company name	Immunome, Inc.
Country	United States
Country code	US
Cusip	45257U108
Employees	177
Employees Change	59%
Employees Change Percent	50
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-10-02
Isin	US45257U1088
Last refreshed	2026-05-10
Market cap	$2.5B
Market cap category	Mid-Cap
Price	$22.44
Price currency	USD
Rev Per Employee	39,214.69x
Sector	Healthcare
Sic	2834
Symbol	IMNM
Website	https://immunome.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.36%
EV Sales Forward	289.29x
EV/Sales	272.54x
FCF yield	-7.89%
P/B ratio	4x
P/S ratio	366.13x
PS Forward	388.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-170.3M
Net Income	$-212.4M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-3,059.99%
Profit Per Employee	$-1.2M
ROA	-28.98
Roa5y	-37.23
ROCE	-33.55
ROE	-52.09
Roe5y	-114.4
ROIC	-32.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	202.25%
Cagr3y	60.75%
Cagr5y	0.42%
EPS Growth Quarters	5
EPS Growth Years	2
Revenue Growth	-23.23x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$683.2M
Cash	$653.5M
Current Assets	$660.8M
Current Liabilities	$45M
Debt	$3.9M
Debt Equity	$0.01
Equity	$634.3M
Liabilities	$48.8M
Long Term Assets	$22.4M
Long Term Liabilities	$3.9M
Net Cash	$649.6M
Net Cash By Market Cap	$25.56
Net Cash Growth	205.75%
Net Debt Equity	$-1.02
Tangible Book Value	$634.3M
Tangible Book Value Per Share	$5.61
WACC	15.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.69
Net Working Capital	$-37.7M
Quick ratio	14.53
Working Capital	$615.8M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-48.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	202.02%
200-day SMA	17.93
3Y total return	315.56%
50-day SMA	21.99
50-day SMA vs 200-day SMA	50over200
5Y total return	2.09%
All Time High	63.78
All Time High Change	-64.82%
All Time High Date	2021-02-18
All Time Low	2.09
All Time Low Change	973.68%
All Time Low Date	2022-05-11
ATR	1.11
Beta	2.11
Beta1y	0.62
Beta2y	1.57
Ch YTD	4.47
High	22.71
High52	27.65
High52 Date	2026-02-04
High52ch	-18.84%
Low	22.05
Low52	7.28
Low52 Date	2025-05-08
Low52ch	208.45%
Ma50ch	2.04%
Premarket Change Percent	1.01
Premarket Price	$22.41
Premarket Volume	201
Price vs 200-day SMA	25.17%
RSI	47.4
RSI Monthly	63.18
RSI Weekly	57.7
Sharpe ratio	1.86x
Sortino ratio	3.29
Total Return	-48.96%
Tr YTD	4.47
Tr1m	3.99%
Tr1w	-1.28%
Tr3m	-9.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	4
Analyst Price Target Top	$36.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.56
Earnings Revenue Estimate	533,336x
Earnings Revenue Estimate Growth	-81.77x
Operating Income	$-214.1M
Operating margin	-3,084.8
Price target	$32.8
Price Target Change	$46.17
Price Target Change Top	$62.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	94,421,425%
Float Percent	83.37%
Shares Insiders	1.15%
Shares Institutions	91.14%
Shares Out	113,249,519
Shares Qo Q	7.93%
Shares Yo Y	48.96%
Short Float	19.7%
Short Ratio	12.38
Short Shares	16.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-226.3M
Average Volume	821,126.35x
Bv Per Share	5.61
CAPEX	$-9.7M
Ch1m	3.99
Ch1w	-1.28
Ch1y	202
Ch3m	-9.81
Ch3y	315.6
Ch5y	2.09
Ch6m	47.24
Change	1.13%
Change From Open	1.13
Close	22.19
Days Gap	0
Depreciation Amortization	2,466,000
Dollar Volume	14,041,605.6
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-214.1M
EBITDA	$-211.6M
EPS	$-2.43
F Score	2
FCF	$-200.6M
FCF EV Yield	-10.6x
FCF Per Share	$-1.77
Financing CF	640,357,000
Fiscal Year End	December
Founded	2,006
Investing CF	60,803,000
Ipr	87
Iprfo	43.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-03
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	20.51
Ma150ch	9.4%
Ma20	23.27
Ma20ch	-3.57%
Net CF	510,241,000
Next Earnings Date	2026-05-22
Open	22.19
Optionable	Yes
Position In Range	59.09
Post Close	22.44
Postmarket Change Percent	0.62
Postmarket Price	$22.58
Ppne	17,614,000
Pre Close	22.19
Price Date	2026-05-08
Ptbv Ratio	4.01
Relative Volume	0.76x
Revenue	6,941,000x
SBC By Revenue	370.12x
Share Based Comp	25,690,000
Tr6m	47.24%
Us State	Washington
Volume	625,740
Z Score	10.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMNM pay a dividend?

Capital-return profile for this ticker.

Performance

IMNM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMNM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+91.1%

Float: +83.4% of shares outstanding

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMNM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.4

Neutral momentum band

Price vs 200-day MA

+25.2%

50/200-day relationship not available

Beta (5Y)

2.11

More volatile than the market

Sharpe ratio

1.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMNM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMNM stock rating?

Immunome, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMNM analysis?

The full report lives at /stocks/IMNM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMNM?

The latest report frames IMNM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMNM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.